Shares of Innophos Holdings, Inc. (NASDAQ:IPHS) have been given a consensus broker rating score of 2.00 (Buy) from the two brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and one has issued a strong buy rating on the company. Innophos’ rating score has improved by 33.3% in the last 90 days as a result of a number of analysts’ ratings changes.
Brokerages have set a 1-year consensus target price of $51.00 for the company and are forecasting that the company will post $0.43 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Innophos an industry rank of 215 out of 255 based on the ratings given to its competitors.
Several research analysts have recently commented on IPHS shares. Seaport Global Securities started coverage on Innophos in a report on Thursday, February 21st. They set a “buy” rating on the stock. BidaskClub raised Innophos from a “strong sell” rating to a “sell” rating in a report on Tuesday, January 15th. ValuEngine raised Innophos from a “strong sell” rating to a “sell” rating in a report on Monday, February 4th. TheStreet raised Innophos from a “c” rating to a “b-” rating in a report on Thursday, February 21st. Finally, Zacks Investment Research raised Innophos from a “strong sell” rating to a “hold” rating in a report on Friday, January 4th.
A number of large investors have recently bought and sold shares of the business. Bank of Montreal Can lifted its stake in Innophos by 79.8% in the 4th quarter. Bank of Montreal Can now owns 1,300 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 577 shares during the last quarter. Public Employees Retirement System of Ohio grew its position in Innophos by 14.1% in the 4th quarter. Public Employees Retirement System of Ohio now owns 2,708 shares of the specialty chemicals company’s stock worth $66,000 after purchasing an additional 334 shares in the last quarter. Quantamental Technologies LLC bought a new stake in Innophos in the 4th quarter worth about $81,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in Innophos in the 3rd quarter worth about $208,000. Finally, Metropolitan Life Insurance Co. NY grew its position in Innophos by 353.5% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 6,403 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 4,991 shares in the last quarter. 93.45% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ:IPHS traded up $0.08 during mid-day trading on Monday, reaching $30.70. 1,944 shares of the company’s stock were exchanged, compared to its average volume of 131,498. The firm has a market cap of $602.68 million, a PE ratio of 13.47 and a beta of 1.33. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.13 and a current ratio of 2.52. Innophos has a twelve month low of $22.57 and a twelve month high of $50.40.
Innophos (NASDAQ:IPHS) last released its quarterly earnings data on Wednesday, February 20th. The specialty chemicals company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.03. The business had revenue of $192.74 million during the quarter, compared to analyst estimates of $189.60 million. Innophos had a net margin of 4.50% and a return on equity of 13.39%. Innophos’s revenue was down .2% compared to the same quarter last year. During the same period last year, the business earned $0.52 EPS. Sell-side analysts forecast that Innophos will post 2.23 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 8th were issued a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 6.25%. The ex-dividend date of this dividend was Thursday, March 7th. Innophos’s payout ratio is currently 84.21%.
Innophos Company Profile
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Read More: Market Capitalization
Get a free copy of the Zacks research report on Innophos (IPHS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.